Cancer Family
Malignant Head and Neck Neoplasm
CI-CAN-00000236Explore in graph →
1,432 active trials17 approved drugs142 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000236Explore in graph →
Clinical trials
5,449 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (629)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01116843 | Study to Assess Biomarkers in Patients With Resectable Oral Cavity Cancer Randomized to Receive Preoperative Treatment | completed | Phase 1 / Phase 2 | 13 | University Health Network, TorontoOTHER | 1 | Jul 10, 2015 | clinicaltrials |
| NCT00281840 | Bevacizumab, Docetaxel, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer | completed | Phase 2 | 30 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 9, 2015 |
| clinicaltrials |
| NCT00508664 | Docetaxel, Cisplatin (TP) + Radiation +/- Cetuximab in Larynx Carcinoma (CA)(DeLOS II) | completed | Phase 2 | 180 | ClinAssessOTHER | 2 | Jun 2, 2015 | clinicaltrials |
| NCT00570232 | UAB 0718 - Phase II Trial to Assess Target Oral Therapy as Adjuvant Chemoprevention in High-Risk Head and Neck Cancer(UAB0718) | completed | Phase 2 | 31 | University of Alabama at BirminghamOTHER | 1 | May 21, 2015 | clinicaltrials |
| NCT01152840 | Study of RAD001 in Adenoid Cystic Carcinoma(ACCRAD001) | completed | Phase 2 | 33 | Seoul National University HospitalOTHER | 1 | May 20, 2015 | clinicaltrials |
| NCT00827164 | Resistance Training During Radiation Therapy for Pharyngeal or Laryngeal Cancer | completed | Phase 2 | 29 | University of Alabama at BirminghamOTHER | 1 | May 12, 2015 | clinicaltrials |
| NCT00458978 | Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer | completed | Phase 2 | 6 | National Cancer Institute (NCI)NIH | 1 | May 5, 2015 | clinicaltrials |
| NCT00713219 | Docetaxel + Cetuximab + Concurrent Re-Irradiation (Intensity - Modulated Radiation Therapy, IMRT) for Patients With Locoregionally Recurrent Head and Neck Cancer | completed | Phase 2 | 14 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 23, 2015 | clinicaltrials |
| NCT00114283 | Lapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck Cancer | completed | Phase 2 | 30 | National Cancer Institute (NCI)NIH | 1 | Apr 15, 2015 | clinicaltrials |
| NCT01790204 | A Study of the Effects of PEITC on Oral Cells With Mutant p53 | completed | Phase 1 / Phase 2 | 55 | Georgetown UniversityOTHER | 1 | Mar 23, 2015 | clinicaltrials |
| NCT01596933 | Effect of Omega-3 Supplements on the Prevention of Cachexia in Head and Neck Cancer Treated With Radio(Chemo)Therapy(NUTRIOM) | completed | Phase 2 / Phase 3 | 91 | General Hospital GroeningeOTHER | 1 | Mar 10, 2015 | clinicaltrials |
| NCT01032928 | Respiratory-Swallow Training in Veterans With Oropharyngeal Cancer(RSPT) | completed | Phase 2 | 30 | US Department of Veterans AffairsFED | 1 | Jan 1, 2015 | clinicaltrials |
| NCT00330382 | Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Patients With Oral Leukoplakia | completed | Phase 2 | 325 | National Cancer Institute (NCI)NIH | 1 | Dec 19, 2014 | clinicaltrials |
| NCT01283334 | A Study of Carboplatin, Cetuximab and RAD001 in Advanced Head and Neck Cancer | completed | Phase 1 / Phase 2 | 20 | Emory UniversityOTHER | 1 | Dec 4, 2014 | clinicaltrials |
| NCT01164176 | Everolimus in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer | completed | Phase 2 | 40 | Yonsei UniversityOTHER | 1 | Dec 2, 2014 | clinicaltrials |
| NCT01964144 | An Open-label, Multicenter, Phase II Study of Dovitinib in Advanced Thyroid Cancer | completed | Phase 2 | 40 | Yonsei UniversityOTHER | 1 | Dec 2, 2014 | clinicaltrials |
| NCT00002932 | Cisplatin and Radiation Therapy in Treating Patients With Stage IV Cancer of the Head and Neck | completed | Phase 2 | 60 | Radiation Therapy Oncology GroupNETWORK | 1 | Nov 21, 2014 | clinicaltrials |
| NCT00697905 | Combination of Gemcitabine and Carboplatin in Metastatic or Recurrent Nasopharyngeal Carcinoma | completed | Phase 2 | 18 | Ministry of Health, MalaysiaOTHER_GOV | 1 | Nov 21, 2014 | clinicaltrials |
| NCT01417143 | Dovitinib in Adenoid Cystic Carcinoma | completed | Phase 2 | 33 | Seoul National University HospitalOTHER | 1 | Nov 13, 2014 | clinicaltrials |
| NCT01465308 | The Effect of Honey on Xerostomia and Oral Mucositis(AC-H) | completed | Phase 2 | 72 | Cyprus University of TechnologyOTHER | 1 | Oct 8, 2014 | clinicaltrials |
| NCT00507767 | Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer | completed | Phase 2 | 15 | National Cancer Institute (NCI)NIH | 1 | Oct 1, 2014 | clinicaltrials |
| NCT00134043 | Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurrent Thyroid Cancer | completed | Phase 2 | 19 | National Cancer Institute (NCI)NIH | 1 | Aug 11, 2014 | clinicaltrials |
| NCT00113334 | Study of ABT-510 (Thrombospondin Analogue) in Patients With Advanced Head and Neck Cancer | completed | Phase 1 / Phase 2 | 6 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 7, 2014 | clinicaltrials |
| NCT00049140 | EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck Cancer | completed | Phase 2 | 8 | David M. Brizel, MDOTHER | 1 | Jul 25, 2014 | clinicaltrials |
| NCT00387335 | Sunitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer | completed | Phase 2 | 22 | National Cancer Institute (NCI)NIH | 1 | Jul 25, 2014 | clinicaltrials |
| NCT00002774 | Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer | completed | Phase 2 | 63 | Stanford UniversityOTHER | 1 | Jun 20, 2014 | clinicaltrials |
| NCT00141765 | Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers | completed | Phase 2 | 25 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jun 20, 2014 | clinicaltrials |
| NCT00101348 | Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 66 | National Cancer Institute (NCI)NIH | 1 | Jun 11, 2014 | clinicaltrials |
| NCT00918281 | Reproducibility of 18F Uptake by Solid Tumors Using PET Imaging Following Intravenous Administration of (18F) Injection | completed | Phase 2 | 70 | GE HealthcareINDUSTRY | 1 | Jun 9, 2014 | clinicaltrials |
| NCT01425736 | Nimotuzumab in Combination With TPF(Cisplatin ,Fluorouracil and Docetaxel) for Head and Neck Squamous Cell Carcinoma | completed | Phase 2 | 91 | Wei GuoOTHER | 1 | Jun 3, 2014 | clinicaltrials |
| NCT00098813 | Romidepsin in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radioactive Iodine | completed | Phase 2 | 20 | National Cancer Institute (NCI)NIH | 1 | May 28, 2014 | clinicaltrials |
| NCT00103259 | Bortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck | completed | Phase 2 | 71 | National Cancer Institute (NCI)NIH | 1 | May 23, 2014 | clinicaltrials |
| NCT00492089 | Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer | completed | Phase 2 | 11 | National Cancer Institute (NCI)NIH | 1 | May 9, 2014 | clinicaltrials |
| NCT00513435 | Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer | completed | Phase 2 | 9 | National Cancer Institute (NCI)NIH | 1 | Apr 30, 2014 | clinicaltrials |
| NCT00148122 | A Study of a New Combination and Schedule of Chemotherapy Drugs for the Treatment of Head and Neck Cancer | completed | Phase 2 | 40 | University of Michigan Rogel Cancer CenterOTHER | 1 | Apr 17, 2014 | clinicaltrials |
| NCT00971932 | Study of Cetuximab in Combination With Chemotherapy in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN) | completed | Phase 2 | 33 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 1 | Apr 8, 2014 | clinicaltrials |
| NCT00589667 | A Phase II Study of Pemetrexed Plus Gemcitabine for Metastatic/Recurrent Head and Neck Cancer (HNSCC) | completed | Phase 2 | 26 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 2, 2014 | clinicaltrials |
| NCT00959387 | Induction Chemotherapy for Advanced Head and Neck Cancer | completed | Phase 2 | 60 | Barretos Cancer HospitalOTHER | 1 | Mar 26, 2014 | clinicaltrials |
| NCT01712919 | Chemoradiation Plus Weekly c225 Against Locoregionally Advanced Nasopharyngeal Carcinoma (NPC) | completed | Phase 1 / Phase 2 | 61 | Jiangsu Cancer Institute & HospitalOTHER | 1 | Mar 24, 2014 | clinicaltrials |
| NCT00865098 | Study of Cetuximab With Concomitant-boost Radiotherapy in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN) | completed | Phase 2 | 27 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 1 | Mar 12, 2014 | clinicaltrials |
| NCT00061906 | Celecoxib in Treating Patients With Progressive Metastatic Differentiated Thyroid Cancer | completed | Phase 2 | 25 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Feb 11, 2014 | clinicaltrials |
| NCT02055989 | A Phase I/II Study of the Use of Intensity Modulated Radiotherapy (IMRT) in Cancer of the Thyroid, Larynx and Hypopharynx | completed | Phase 1 / Phase 2 | 105 | Royal Marsden NHS Foundation TrustOTHER | 1 | Feb 5, 2014 | clinicaltrials |
| NCT00791141 | Adjuvant Cetuximab and Chemoradiation in Head and Neck Cancer(ACCRA-HN) | completed | Phase 2 | 80 | Heinrich-Heine University, DuesseldorfOTHER | 1 | Jan 23, 2014 | clinicaltrials |
| NCT00203905 | A Study of Chemoradiotherapy for Intermediate Stage/Selected Stage IV Cancers of the Head and Neck | completed | Phase 2 | 23 | University of ChicagoOTHER | 1 | Jan 17, 2014 | clinicaltrials |
| NCT00098631 | Lapatinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer | completed | Phase 2 | 88 | National Cancer Institute (NCI)NIH | 1 | Jan 7, 2014 | clinicaltrials |
| NCT00334997 | Endoscopic Surgery or Radiation Therapy in Treating Patients With Stage 0, Stage I, or Stage II Laryngeal Cancer of the Glottis | completed | Phase 2 | 50 | University College London HospitalsOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT01865201 | Effect of Edaravone on Radiation-induced Temporal Lobe Necrosis | completed | Phase 2 | 154 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Dec 12, 2013 | clinicaltrials |
| NCT00055770 | Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck Cancer | completed | Phase 1 / Phase 2 | 45 | National Cancer Institute (NCI)NIH | 1 | Nov 25, 2013 | clinicaltrials |
| NCT01172769 | Efficacy Study of Temsirolimus to Treat Head and Neck Cancer(TEMHEAD) | completed | Phase 2 | 42 | Hannover Medical SchoolOTHER | 1 | Nov 8, 2013 | clinicaltrials |
| NCT00004256 | Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for Laryngeal Cancer | completed | Phase 2 | — | Royal Marsden NHS Foundation TrustOTHER | 1 | Nov 6, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Jul 10, 2015source: clinicaltrials